PEG Biosciences

PEG Biosciences refers to a group of entities with shared or similar names, operating in distinct but related areas of life sciences. PEG Biosciences Inc. in the US (and related Biopharma PEG Scientific Inc.) is primarily a commercial supplier and manufacturer of high-purity polyethylene glycol (PEG) derivatives and linkers for pharmaceutical R&D, operating under proprietary BioSynersys™ and ProbioTherapeutic™ technologies. They offer GMP capabilities for reagent manufacturing. In contrast, PegBio (派格生物医药（杭州）股份有限公司) based in Hangzhou, China, is a clinical-stage biotechnology company focused on developing novel therapies for chronic diseases, particularly metabolic disorders. PegBio leverages its HECTOR™ platform and has a pipeline including peptide, protein, and small molecule drugs for indications such as T2DM, obesity, MASH, OIC, and congenital hyperinsulinism, with at least one core product and five pipeline products.